514 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Cardinal Health recalled all lots of Salem Sump stomach tubes on September 18, 2025. The recall affects tubes with product codes 264929, 264945, and others due to complaints of valve breakage. Patients and healthcare providers should stop using the devices immediately.
Cardinal Health 200 recalled Salem Sump PVC gastroduodenal tubes on September 18, 2025. The recall affects all lots sold worldwide due to complaints of Anti-Reflux Valve breakage. Patients and healthcare providers must stop using the devices immediately.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Baxter Healthcare recalled 5,209 oral probes on September 17, 2025. The probes were incorrectly programmed to show lower temperatures, risking delayed treatment for fever-related symptoms. Consumers and healthcare providers must stop using the affected probes immediately.
CPM Medical Consultants recalled 3,317 units of its foot plating system on September 17, 2025. The recall addresses updated sterilization instructions that incorrectly included requirements not applicable in the U.S. Patients and healthcare providers must stop using the device immediately.
Accord Healthcare recalled 54,432 bottles of Levothyroxine Sodium Tablets on September 16, 2025. The tablets were found to be subpotent during stability testing. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Abiomed recalled 9,177 Automated Impella Controllers on September 16, 2025. The recall follows reports of purge pressure issues due to purge retainer failures. Patients and healthcare providers must stop using the devices immediately.
FUJIFILM Healthcare Americas recalled 16 units of the CH-200 X-ray tube support on September 15, 2025, due to a potential shaft failure. The broken shaft could render protective components ineffective, posing a high risk during operation. Healthcare providers and patients must stop using the device immediately.
American Health Packaging recalled 360 cartons of Carbamazepine Extended-Release Tablets on September 15, 2025. The tablets fail to meet dissolution specifications, posing a risk to patients. Consumers should stop using the product immediately and consult healthcare providers for guidance.
Graviti Pharmaceuticals recalled 46,512 bottles of Bupropion Hydrochloride Extended-Release Tablets on September 15, 2025. The recall stems from failed tablet specifications that could affect safety and efficacy. The product was distributed to pharmacies nationwide.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Private Label Skin Care recalled 125 units of ARTISAN OF SKIN Benzoyl Peroxide 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers should stop using the product immediately and seek guidance.
Private Label Skin Care recalled its edunn clarity BP Treatment Cleanser on September 12, 2025. Elevated benzene levels prompted the recall after post-consumer awareness. The product was distributed in California and Georgia.
Private Label Skin Care recalled its 7 oz Acne Treatment on September 12, 2025. Elevated levels of benzene prompted the recall, classified as Class II. The affected product was distributed in California and Georgia only.
Private Label Skin Care recalled Benzaderm BPO Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall affecting consumers in California and Georgia. No injuries have been reported.
Major Pharmaceuticals recalled 866 blister packs of Chlorpromazine Hydrochloride Tablets on September 12, 2025. The recall follows the detection of N-Nitroso Desmethyl Chlorpromazine above safe limits. The affected products were distributed nationwide and are classified as a Class II hazard.
Major Pharmaceuticals recalled 2,064 blister packs of Chlorpromazine Hydrochloride Tablets on September 12, 2025. The recall follows the discovery of N-Nitroso Desmethyl Chlorpromazine exceeding safe limits. Consumers must stop using this product immediately and consult healthcare providers for guidance.
Major Pharmaceuticals announced a recall of 1,256 blister packs of Chlorpromazine Hydrochloride Tablets on September 12, 2025. The recall stems from the presence of N-Nitroso Desmethyl Chlorpromazine above safe intake levels. Consumers must stop using the product immediately and contact their healthcare provider for guidance.
Major Pharmaceuticals recalled 506 blister packs of Chlorpromazine Hydrochloride tablets on September 12, 2025. The recall stems from CGMP deviations due to the presence of N-Nitroso Desmethyl Chlorpromazine above safe limits. Consumers should stop using the product immediately and consult healthcare providers.
Major Pharmaceuticals recalled 1,394 blister packs of Chlorpromazine Hydrochloride Tablets due to contamination concerns. The recall occurred on September 12, 2025, after the FDA found N-Nitroso Desmethyl Chlorpromazine above acceptable limits. Consumers should stop using these tablets and seek guidance from healthcare providers.
UIH Technologies recalled two units of the uEXPLORER MD system on September 12, 2025. Third-party covers can trap between the patient table and gantry, causing mechanical interference. Healthcare providers must stop using the device immediately and follow recall instructions.
Diagnostica Stago recalled 12,740 D-Dimer testing devices on September 12, 2025. The recall follows a risk of underestimating D-Dimer levels in patients. Healthcare providers and patients should stop using the device immediately.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.